FDA Grants Fast Track Designation to Drug Candidate for Celiac Disease
The FDA has granted fast track designation to TEV-53408 (Teva Pharmaceutical Industries, Ltd), an investigational anti-IL-15 antibody designed for the treatment of individuals with celiac dise...